17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dioscin has shown cytotoxicity against cancer cells, but its poor solubility and stability have limited its clinical application. In this study, we designed mixed micelles composed of TPGS and Soluplus(®) copolymers entrapping the poorly soluble anticancer drug dioscin.

          Related collections

          Author and article information

          Journal
          Drug Dev Ind Pharm
          Drug development and industrial pharmacy
          Informa UK Limited
          1520-5762
          0363-9045
          Jul 2017
          : 43
          : 7
          Affiliations
          [1 ] a School of Pharmacy, Dalian Medical University , Dalian , P.R. China.
          Article
          10.1080/03639045.2017.1304956
          28300426
          e97a507d-661d-4f04-8da1-c5be45579f8e
          History

          Dioscin,Soluplus,TPGS,cancer therapy,mixed micelles
          Dioscin, Soluplus, TPGS, cancer therapy, mixed micelles

          Comments

          Comment on this article